NEWS

Source: Tech Point
Boomerang Ventures is backing SynchNeuro’s pioneering effort to build the world’s first brain-based, non-invasive continuous glucose monitor. Using EEG-derived brainwave signals decoded by machine learning, SynchNeuro aims to track blood glucose and cardiometabolic indicators via a discreet wearable placed behind the ear. This seed-stage investment will help speed development of the “Cardiometabolic Advisor” system and bring proactive, needle-free monitoring closer to mass market.